SYBILLA (Systems biology of T-cell activation in health and disease)
SYBILLA, systems biology of T-cell activation in health and disease, is a European Union-funded large integrated project in framework program 7 (FP7). It is funded for 5 years with 11.1 mio Euro and started in April 2008. It has 14 scientific and 3 industrial partners from 11 countries, lead by Dr. Wolfgang Schamel, Max Planck-Institute for Immunobiology, Freiburg, Germany, as the scientific coordinator.The goal of SYBILLA is to understand the intracellular signalling network of T cells that determines T cell fate.
SYBILLA is participating in the 16th Signal Transduction Society (STS) international conference "Signal Transduction: Receptors, Mediators and Genes" with a focus on immune cell signalling from the 5th to 7th November 2012 in Weimar, Germany.
Download the Flyer.
"Every part is reciprocally both end and means. In such a product nothing is in vain, without an end, or to be ascribed to a blind mechanism of nature."